Results 11 to 20 of about 34,736 (244)

Distinction of NPY receptors in vitro and in vivo. II. Differential effects of NPY and NPY-(18-36)

open access: yesAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990
We have studied the hemodynamic effects of neuropeptide Y (NPY) and its COOH-terminal fragment NPY-(18–36) in conscious rats. Intra-arterial injection of NPY rapidly elevated systemic vascular resistance (SVR), which remained high for greater than 30 min. Cardiac output (CO) decreased, and it remained low for greater than 30 min.
Scott, N. A.   +7 more
openaire   +4 more sources

Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro

open access: yesAmerican Journal of Physiology-Endocrinology and Metabolism, 1990
We studied the possibility of multiple neuropeptide Y (NPY) receptor subtypes. NPY-stimulated Ca2+ mobilization in human erythroleukemia (HEL) cells was used to screen a number of NPY analogues. The potencies of three of these analogues [peptide YY (PYY), [D-Tyr-36]NPY, and NPY-(18-36)] were compared with that of NPY in the following model systems: Ca2+
Michel, M. C.   +9 more
openaire   +4 more sources

NPY and Cardiac Diseases

open access: yesCurrent Topics in Medicinal Chemistry, 2007
Hypertension-induced left ventricular hypertrophy (LVH), along with ischemic heart disease, result in LV remodeling as part of a continuum that often leads to congestive heart failure. The neurohormonal model has been used to underpin many treatment strategies, but optimal outcomes have not been achieved.
McDermott, Barbara, Bell, David
core   +5 more sources

Neuropeptide Y (NPY) : A neurogenic mediator of angiogenesis

open access: yes, 2004
NPY, previously known as a sympathetic vasoconstricting co-transmitter, recently has also emerged as an important vascular growth factor, stimulating proliferation of vascular smooth muscle and endothelial cells (ECs).
Michalkiewicz, Mieczyslaw   +6 more
core   +9 more sources

Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease

open access: yesArchives of Oral Biology, 2009
Neuropeptide Y (NPY) coordinates inflammation and bone metabolism which are central to the pathogenesis of periodontitis. The present study was designed to determine whether NPY was quantifiable in human gingival crevicular fluid (GCF) and to test the null hypothesis that GCF levels of NPY were the same in periodontal health and disease.
Lundy, Fionnuala T.   +2 more
openaire   +4 more sources

NPY in alcoholism and psychiatric disorders

open access: yes, 2006
The NPY system may well be one of the most interesting target systems for development of treatments for alcohol dependence as well as mood disorders such as depression and anxiety syndromes. NPY is an endogenous anxiolytic compound, functions as an antidepressant, and is effective in modifying alcohol intake in high drinking states.
Annika, Thorsell   +2 more
openaire   +3 more sources

<i>Hj</i>-aggregates of quinoline-fused boron-dipyrromethene nanoparticles for near-infrared dualmodal photodynamic and photothermal therapy. [PDF]

open access: yesSmart Mol
A novel quinoline‐fused cyclic pyrrole is synthesized via lithium diisopropylamide‐catalyzed [3 + 2] cyclization, enabling the construction of a symmetrical boron‐dipyrromethene photosensitizer that forms Hj‐aggregates upon nanoparticle encapsulation.
Zhang B   +6 more
europepmc   +2 more sources

Placental Neuropeptide Y ( NPY ) and NPY receptors expressions and serum NPY levels in preeclampsia [PDF]

open access: yesExperimental Biology and Medicine, 2019
Neuropeptide Y (NPY) has been reported as a vasoconstrictive substance that might be associated with preeclampsia. NPY mediates different effects via its specific NPY receptors. NPY action via Y1 receptor (Y1R) and/or Y5 receptor (Y5R) induces vascular smooth muscle cells proliferation while it is implicated in angiogenesis via Y2 receptor (Y2R) and/or
Roongrit Klinjampa   +7 more
openaire   +2 more sources

Modulation of neuropeptide Y levels is impaired in crack withdrawal patients

open access: yesTrends in Psychiatry and Psychotherapy, 2020
Introduction The dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has a key role in drug addiction susceptibility. In addition to the well-known relationship between cortisol and the HPA axis, other molecules are involved with stress ...
Fabiana Galland   +7 more
doaj   +1 more source

sj-npy-5-asq-10.1177_00018392231180872 – Supplemental material for Doing Organizational Identity: Earnings Surprises and the Performative Atypicality Premium

open access: yes, 2023
Supplemental material, sj-npy-5-asq-10.1177_00018392231180872 for Doing Organizational Identity: Earnings Surprises and the Performative Atypicality Premium by Paul Gouvard, Amir Goldberg and Sameer B.
Paul Gouvard (16379778)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy